companydata.dkRenescience A/S: Financial statements 2014
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -26,446,000 and a net result of DKK -19,400,000 compared with DKK -19,925,000 the year before. Equity amounted to DKK 33,280,000. The solvency ratio was 87%.
- Gross Profit
- -26,446,000 kr.
- Profit/Loss
- -19,400,000 kr.
- Equity
- 33,280,000 kr.
- Total Assets
- 38,231,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
| 2012 | - | -21 mio. | -16.6 mio. | 17.6 mio. | - |
Keep an eye on Renescience A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
Renescience A/S has published its annual report for 2013. Gross profit came to DKK -25,570,000, and the net result was DKK -19,925,000.
As of May 28, 2014, Jacob Moesgård has joined the board of directors of Renescience A/S.
As of May 28, 2014, Mikael Brandt has left the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.